US 8722046
Human monoclonal antibodies protective against bubonic plague
granted A61KA61K2039/505A61P
Quick answer
US patent 8722046 (Human monoclonal antibodies protective against bubonic plague) held by The United States of America as represented by the Secretary of the Army expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61P, A61P31/04